Robotic surgery in the treatment of oropharyngeal cancer: a case report
https://doi.org/10.21294/1814-4861-2023-22-5-190-196
Abstract
Background. The incidence of HpV-associated oropharyngeal squamous cell carcinoma (oscc) is steadily increasing. given the better prognosis in patients with HpV-positive cancer compared to HpV-negative cancer, attempts were made to reduce the therapeutic effect in patients with early-stage oscc to improve the quality of life of these patients. early-stage oscc can currently been treated with radiation therapy or surgery used alone or in combination. Currently, the concept of transoral surgery includes both transoral laser microsurgery and robot-assisted surgeries (da Vinci, medrobotics Flex system). Case description. We report a case of using the da Vinci robot-assisted system in the combined modality treatment of oropharyngeal cancer. The patient underwent surgery followed by chemoradiotherapy. At a follow-up of 10 months, no evidence of disease progression was found. The patient experienced no any pain on swallowing.
Conclusion. The use of the da Vinci robot-assisted surgical system in the combined modality treatment of oropharyngeal cancer, especially in such a hard-to-reach area as the root of the tongue, makes it possible to better visualize and determine the boundaries of the lesion, followed by en block resection, as well as to improve functional and aesthetic results. However, careful selection of patients for this type of treatment is necessary.
About the Authors
O. A. Saprina
N.N. Blokhin National medical Research centre of oncology
Russian Federation
Russian Federation
Oxana A. Saprina - MD, PhD, Senior Researcher, Department of Head and Neck Cancer Surgery.
23, Kashirskoe shosse, Moscow, 1154786
M. A. Kropotov
N.N. Blokhin National medical Research centre of oncology
Russian Federation
Russian Federation
Mikhael A. Kropotov - MD, DSc, Head of Department of Head and Neck Cancer Surgery.
23, Kashirskoe shosse, Moscow, 1154786
E. A. Zanozina
N.N. Blokhin National medical Research centre of oncology
Russian Federation
Russian Federation
Ekaterina A. Zanozina - MD, Resident.
23, Kashirskoe shosse, Moscow, 1154786
References
1. Malignant tumors in Russia in 2021 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2022. 252 p. (in Russian).
2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Cancer of the Oropharynx. Version 2.2018.
3. Ragin C.C., Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007; 121(8): 1813–20. doi: 10.1002/ijc.22851.
4. Allen C.T., Lewis J.S., El-Mofty S.K., Haughey B.H., Nussenbaum B. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope. 2010; 120(9): 1756–72. doi: 10.1002/lary.20936.
5. Moore E.J., Olsen S.M., Laborde R.R., García J.J., Walsh F.J., Price D.L., Janus J.R., Kasperbauer J.L., Olsen K.D. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc. 2012; 87(3): 219–25. doi: 10.1016/j.mayocp.2011.10.007.
6. Grant D.G., Hinni M.L., Salassa J.R., Perry W.C., Hayden R.E., Casler J.D. Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. Arch Otolaryngol Head Neck Surg. 2009; 135(12): 1225–30. doi: 10.1001/archoto.2009.185.
7. Haughey B.H., Hinni M.L., Salassa J.R., Hayden R.E., Grant D.G., Rich J.T., Milov S., Lewis J.S., Krishna M. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011; 33(12): 1683–94. doi: 10.1002/hed.21669.
8. Smith R.V., Schiff B.A., Garg M., Haigentz M. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients. Laryngoscope. 2015; 125(s10): 610–5. doi: 10.1002/lary.25534.
9. Steiner W., Fierek O., Ambrosch P., Hommerich C.P., Kron M. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg. 2003; 129(1): 36–43. doi: 10.1001/archotol.129.1.36.
10. Mirghani H., Blanchard P. Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand? Clin Transl Radiat Oncol. 2017; 8: 4–11. doi: 10.1016/j.ctro.2017.10.005.
Review
For citations:
Saprina O.A., Kropotov M.A., Zanozina E.A. Robotic surgery in the treatment of oropharyngeal cancer: a case report. Siberian journal of oncology. 2023;22(5):190-196. (In Russ.) https://doi.org/10.21294/1814-4861-2023-22-5-190-196
Views:
342
Email this article 
